{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T04:01:46Z","timestamp":1750564906430,"version":"3.41.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1997,5,1]],"date-time":"1997-05-01T00:00:00Z","timestamp":862444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1997,5,1]],"date-time":"1997-05-01T00:00:00Z","timestamp":862444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res Treat"],"published-print":{"date-parts":[[1997,5]]},"DOI":"10.1023\/a:1005749032226","type":"journal-article","created":{"date-parts":[[2002,12,21]],"date-time":"2002-12-21T23:13:52Z","timestamp":1040512432000},"page":"83-89","source":"Crossref","is-referenced-by-count":3,"title":["Urinary steroids at time of surgery in postmenopausal women with breast cancer"],"prefix":"10.1007","volume":"44","author":[{"given":"Susan","family":"Juricskay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Istv\u00e1n","family":"Szab\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K\u00e1roly","family":"Kett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"129612_CR1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1056\/NEJM198001033020104","volume":"302","author":"IC Henderson","year":"1980","unstructured":"Henderson IC, Cannelos GP: Cancer of the breast: the last decade. New Engl J Med 302: 17\u201330, 1980","journal-title":"New Engl J Med"},{"key":"129612_CR2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/0960-0760(92)90393-W","volume":"41","author":"Y Mousavi","year":"1992","unstructured":"Mousavi Y, Adlercreutz H: Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture. J Steroid Biochem Molec Biol 41: 615\u2013619, 1992","journal-title":"J Steroid Biochem Molec Biol"},{"key":"129612_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0960-0760(93)90137-L","volume":"45","author":"JR Pasqualini","year":"1993","unstructured":"Pasqualini JR: Role of androgens in breast cancer. J Steroid Biochem Molec Biol 45: 1\u20133, 1993","journal-title":"J Steroid Biochem Molec Biol"},{"key":"129612_CR4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1093\/oxfordjournals.epirev.a036116","volume":"15","author":"L Bernstein","year":"1993","unstructured":"Bernstein L, Ross RK: Endogenous hormones and breast cancer risk. Epidemiol Rev 15: 48\u201365, 1993","journal-title":"Epidemiol Rev"},{"key":"129612_CR5","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/ijc.2910500603","volume":"50","author":"JB Adams","year":"1992","unstructured":"Adams JB: Human breast cancer: concerted role of diet, prolactin and adrenal C19-n5-steroids in tumorgenesis. Int J Cancer 50: 854\u2013858, 1992","journal-title":"Int J Cancer"},{"key":"129612_CR6","first-page":"799","volume":"12","author":"G Boccuzzi","year":"1992","unstructured":"Boccuzzi G, Brignardello E, Dimonaco M, Forte C, Leonardi L, Pizzini A: Influence of dehydroepiandrosterone and 5-en-androstene-3\u03b2, 17\u03b2-diol on the growth of MCF-7 human breast cancer cells induced by 17-\u03b2-estradiol. Anticancer Res 12: 799\u2013803, 1992","journal-title":"Anticancer Res"},{"key":"129612_CR7","first-page":"3859","volume":"50","author":"GB Gordon","year":"1990","unstructured":"Gordon GB, Bush TL, Helzlsouer KJ, Miller SR, Comstock GW: Relationship of serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing postmenopausal breast cancer. Cancer Res 50: 3859\u20133862, 1990","journal-title":"Cancer Res"},{"key":"129612_CR8","first-page":"3360","volume":"41","author":"B Zumoff","year":"1981","unstructured":"Zumoff B, Levin J, Rosenfeld RS, Jarkham M, Strain GW, Fukusima DK: Abnormal 24-hr mean plasma concentration of dehydroepiandrostene and dehydroepiandrosterone sulfate in women with primary operable breast cancer. Cancer Res 41: 3360\u20133363, 1981","journal-title":"Cancer Res"},{"key":"129612_CR9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0277-5379(88)90173-3","volume":"24","author":"TJA Key","year":"1988","unstructured":"Key TJA, Pike MC: The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 24: 29\u201343, 1988","journal-title":"Eur J Cancer Clin Oncol"},{"key":"129612_CR10","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00666478","volume":"29","author":"YS L\u00f3pez-Boado","year":"1994","unstructured":"L\u00f3pez-Boado YS, Diez-Itza I, Tolivia J, L\u00f3pez-Otin C: Glucocorticoids and androgens up-regulate the Zn-\u03b12-glycoprotein messenger RNA in human breast cancer cells. Breast Cancer Res and Treat 29: 247\u2013258, 1994","journal-title":"Breast Cancer Res and Treat"},{"key":"129612_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00682694","volume":"26","author":"P Ballerini","year":"1993","unstructured":"Ballerini P, Oriana S, Duca P, Martinetti A, Venturelli E, Ferrari L, Dolci S, Secreto G: Urinary testosterone as a marker of risk of recurrence in operable breast cancer. Breast Cancer Res Treat 26: 1\u20136, 1993","journal-title":"Breast Cancer Res Treat"},{"key":"129612_CR12","first-page":"507","volume":"98","author":"C Fan","year":"1985","unstructured":"Fan C, Shu\u00f6shi W, Qing-tai D, Li-ying X, Wan-ying L, Wen-xiu Y, Zhen-guo W: A study on plasma sex hormone levels in patients with breast cancer. Chinese Med J 98: 507\u2013510, 1985","journal-title":"Chinese Med J"},{"key":"129612_CR13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/bjc.1957.43","volume":"11","author":"HJG Bloom","year":"1957","unstructured":"Bloom HJG, Richardson WW: Histological grading and prognosis in breast cancer. Br J Cancer 11: 359\u2013377, 1957","journal-title":"Br J Cancer"},{"key":"129612_CR14","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0009-8981(76)90505-2","volume":"69","author":"C Shackleton","year":"1976","unstructured":"Shackleton C, Honour J: Simultaneous estimation of urinary steroids by semi-automated gas chromatography. Investigation of neonatal infants and children with abnormal steroid synthesis. Clin Chim Acta 69: 267\u2013283, 1976","journal-title":"Clin Chim Acta"},{"key":"129612_CR15","unstructured":"Homoki J, Rodens K, Teller W: Infantile spasm: Urinary steroid excretion during corticotropin (ACTH) treatment. Proc Symp Anal Steroids, Sopron, Hungary, 1987"},{"key":"129612_CR16","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/0960-0760(93)90187-2","volume":"46","author":"R Hackenberg","year":"1993","unstructured":"Hackenberg R, Turgetto I, Filmer A, Schulz KD: Estrogen and androgen receptor mediated stimulation and inhibition of proliferation by androst-5-ene-3\u03b2, 17\u03b2-diol in human mammary cancer cells. J Steroid Biochem Molec Biol 46: 597\u2013603, 1993","journal-title":"J Steroid Biochem Molec Biol"},{"key":"129612_CR17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000217823","volume":"14","author":"MH Liberato","year":"1993","unstructured":"Liberato MH, Sonohara S, Brentani MM: Effects of androgens on proliferation and progesterone receptor levels in T47D human breast cancer cells. Tumor Bio 14: 38\u201345, 1993","journal-title":"Tumor Bio"},{"key":"129612_CR18","first-page":"708","volume":"1","author":"A Pizzini","year":"1992","unstructured":"Pizzini A, Brignardello E, Leonardi L, Di Monaco G: Aromatase fails to mediate the proliferative effects of adrenal androgens on cultured MCF-7 breast cancer cells. Intern J Oncol 1: 708\u2013712, 1992","journal-title":"Intern J Oncol"},{"key":"129612_CR19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00665681","volume":"29","author":"SM Li","year":"1994","unstructured":"Li SM, Yan X, Belanger A, Labrie F: Prevention by dehydroepiandrosterone of the development of mammary carcinoma induced by 7,12-dimethylbenz(A) anthracene (DMBA) in the rat. Breast Cancer Res Treat 29: 203\u2013217, 1994","journal-title":"Breast Cancer Res Treat"},{"key":"129612_CR20","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/0277-5379(85)90025-2","volume":"21","author":"P Hill","year":"1985","unstructured":"Hill P, Garbaczewsi I, Kasumi F: Plasma testosterone and breast cancer. Eur J Cancer 21: 1265\u20131266, 1985","journal-title":"Eur J Cancer"},{"key":"129612_CR21","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0140-6736(76)90064-7","volume":"I","author":"IJ McFadyen","year":"1976","unstructured":"McFadyen IJ, Forrest APM, Prescott RJ, Groom GV, Golder MP, Fahmy DR: Circulating hormone concentrations in women with breast cancer. Lancer I: 1100\u20131102, 1976","journal-title":"Lancer"},{"key":"129612_CR22","first-page":"2572","volume":"51","author":"G Secreto","year":"1991","unstructured":"Secreto G, Toniolo P, Berrino F, Recchione C, Cavalleri A, Pisani P, Totis A, Fariselli G, Di Pietri S: Serum and urinary androgens and risk of breast cancer in postmenopausal women. Cancer Res 51: 2572\u20132576, 1991","journal-title":"Cancer Res"},{"key":"129612_CR23","first-page":"1","volume":"52","author":"KJ Helzlsouer","year":"1992","unstructured":"Helzlsouer KJ, Gordon GB, Alberg AJ, Bush TL, Comstock GW: Relationship of prediagnostic serum levels of dehydroepiandrosterone and dehydroepiandrosterone sulfate to the risk of developing premenopausal breast cancer. Cancer Res 52: 1\u20134, 1992","journal-title":"Cancer Res"},{"key":"129612_CR24","first-page":"6571","volume":"50","author":"E Barrett-Connor","year":"1990","unstructured":"Barrett-Connor E, Friedlander NJ, Khaw KT: Dehydroepiandrosterone sulfate and breast cancer risk. Cancer Res 50: 6571\u20136574, 1990","journal-title":"Cancer Res"},{"key":"129612_CR25","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0140-6736(71)90113-9","volume":"2","author":"RD Bulbrook","year":"1971","unstructured":"Bulbrook RD, Hayward JL, Spicer CC: Relation between urinary androgen and corticoid excretion and subsequent breast cancer. Lancet 2: 395\u2013398, 1971","journal-title":"Lancet"},{"key":"129612_CR26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/ajcn\/49.3.433","volume":"49","author":"H Adlercreutz","year":"1989","unstructured":"Adlercreutz H, H\u00e4m\u00e4l\u00e4inen E, Gorbach SL, Goldin BR, Woods MN, Dwyer JT: Diet and plasma androgens in postmenopausal vegetarian and omnivorous women and postmenopausal women with breast cancer. Am J Clin Nutr 49: 433\u2013442, 1989","journal-title":"Am J Clin Nutr"},{"key":"129612_CR27","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/bjc.1983.35","volume":"47","author":"G Secreto","year":"1983","unstructured":"Secreto G, Recchione C, Cavalleri A, Miraglia M, Dati V: Circulating levels of testosterone, 17\u03b2-oestradiol, luteinising hormone and prolactin in postmenopausal breast cancer patients. Br J Cancer 47: 269\u2013273, 1983","journal-title":"Br J Cancer"},{"key":"129612_CR28","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0959-8049(94)90415-4","volume":"30A","author":"RA Badwe","year":"1994","unstructured":"Badwe RA, Wang DY, Gregory WM, Fentiman IS, Chaudary MA, Smith P, Richards MA, Rubens RD: Serum progesterone at the time of surgery and survival in women with premenopausal operable breast cancer. Eur J Cancer 30A: 445\u2013448, 1994","journal-title":"Eur J Cancer"},{"key":"129612_CR29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/bjc.1994.291","volume":"70","author":"G Plu-Bureau","year":"1994","unstructured":"Plu-Bureau G, Le MG, Sitruk-Ware R, Thalabard JC, Mauvais-Jarvis P: Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast disease. Br J Cancer 70: 270\u2013277, 1994","journal-title":"Br J Cancer"}],"container-title":["Breast Cancer Research and Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1005749032226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1005749032226\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.springerlink.com\/index\/pdf\/10.1023\/A:1005749032226","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1005749032226.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T04:06:24Z","timestamp":1750478784000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1005749032226"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,5]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,5]]}},"alternative-id":["129612"],"URL":"https:\/\/doi.org\/10.1023\/a:1005749032226","relation":{},"ISSN":["0167-6806","1573-7217"],"issn-type":[{"type":"print","value":"0167-6806"},{"type":"electronic","value":"1573-7217"}],"subject":[],"published":{"date-parts":[[1997,5]]}}}